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Abstract
Peanut allergies are the leading cause of death from food anaphylaxis. In 2017,
the National Association of Allergy and Infectious Disease (NIAID) issued a guideline
for use by primary care providers to identify infants who would benefit from early
peanut consumption. Many providers have not yet implemented these guidelines in
clinical practice. The purpose of this project was to implement a practice change to
improve assessment of risk factors for peanut allergies utilizing the NIAID guideline in
infants at their six-month well-child examination at a pediatric primary care practice.
Risk factors assessed included: a history of eczema and/or egg allergy categorized by
eczema and egg allergy severity. Family history, seen as a moderate risk factor for food
allergy, was also assessed. The risk assessment was implemented by creating a
provider alert on six-month wellness forms and a field for documentation into the
electronic health record. Providers were given education materials for families of
infants who would benefit from safe, early peanut consumption. This project is
important for clinical practice; infants begin consuming solid foods at or around sixmonths of age and this is a critical time to address risk for future allergies and educate
families on benefits of early consumption of allergenic foods, such as peanuts. Primary
Care providers in primary care play a pivotal role in addressing new practice change.
This project provides a framework for provider identifications of at-risk infants to move
toward prevention of lifelong peanut allergy.
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Introduction
The Centers for Disease Control (2017) estimates that 4-6% of children suffer
from food allergies. In those children, 30.4% are allergic to more than one type of food
(American Academy of Allergy, Asthma, and Immunology, n.d.). The prevalence of
food allergies has increased over the last two decades and is a growing public and
global health concern, especially in westernized countries (Tang & Mullins, 2017). It has
been reported that peanut allergies in children in the United States (U.S.) increased from
0.4% in 1999 to 2% in 2010 (Togias et al., 2017). Food allergies are a lifelong issue
carrying an extreme burden of disease for affected children whose families must be
constantly aware to avoiding exposure and trigger risks.
Allergies develop when the immune system overreacts to a foreign substance in
the body. Symptoms range from a mild rash and itching to a severe and possibly fatal
episode of anaphylaxis. Anaphylaxis occurs when there is a large drop in blood
pressure, swelling of the airways making it difficult to breathe, and decreased blood
supply to vital organs, making this a life-threatening emergency (National Institute of
Allergy and Infectious Disease, 2016; Sicherer et al., 2017). Peanut allergies in the U.S.
are the greatest cause of death from food anaphylaxis and are on the rise. The upward
trend in peanut allergies is thought to be due to the fact that allergies are epigenetic,
meaning that they are affected by an interaction between heritable genetics and the
environment. In epigenetic conditions, certain aspects of one’s environment (i.e. diet,
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lifestyle, climate) can trigger expression of a gene whereas other environments may not
(Committee on Food Allergies, 2017). A consensus statement notes indirect evidence
that genetics plays a role in food allergy development and family history is a moderate
risk factor (Sicherer et al., 2017).
Additional risk factors are associated with peanut allergies. Atopic dermatitis
(also known as “eczema”) is a skin condition that affects the skin barrier and causes
inflammation and breakdown. This inflammation of the skin makes an individual more
sensitive when exposed to allergens and proteins in the environment, such as
peanuts. Individuals with co-existing egg allergies have an increased risk for peanut
allergies (Sicherer et al., 2017). The increased prevalence of peanut allergies, occurring
early in childhood, and seldom outgrown, has lead researchers to recommend early
prevention due to increased risk considerations (Du Toit et al., 2015).
The groundbreaking randomized control trial, known as the Learning Early
About Peanut Allergy (LEAP) Trial, showed significant reduction in peanut allergy
with early consumption of peanuts. This large trial included 640 infants 4-11 months
old diagnosed with severe eczema, egg allergy, or both. Prior to randomization of each
child, skin-prick tests were performed and those who were positive for peanut allergies
were separated from those who were negative into two groups for analysis. Each infant
in the two groups (positive vs. negative skin-prick tests) was then randomly assigned to
a peanut consumption or peanut avoidance group until 60 months old. The
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consumption group was defined at consuming 2 grams of peanut protein at one specific
time during the first and second year of life, in addition to consuming 3 grams of
peanut protein (12g or roughly 3 teaspoons of peanut butter) each week for 50% of the
weeks during data collection (Du Toit et al., 2015).
At the end of the trial, infants in the negative versus the positive skin-prick tests
prior to randomization were evaluated to determine presence of peanut allergy. In the
group of infants with a negative skin-prick test at initiation, 13.7% in the peanut
avoidance group had peanut allergies while only 1.9% of the peanut consumption
group had peanut allergies; a relative risk reduction of 86.1%. The infants with positive
skin-prick tests in the peanut avoidance group, 35.5% had peanut allergies, whereas
10.6% of infants in the peanut consumption group had peanut allergies at the end of
data analysis; a relative risk reduction of 70%. Authors stated these outcomes show that
early consumption of peanuts can prevent allergies at both the primary, prior to the
disease occurring, and secondary, targeting those at risk for disease, levels (Du Toit et
al., 2015).
The LEAP trial was extremely successful in showing that early
intervention in consumption of peanuts can significantly reduce allergy prevalence at
five years of life. Researchers performed a continuation of this study, the LEAP-On
trial, to determine if tolerance to peanuts persisted after 12 months of avoiding
consumption. This study consisted of 550 participants from the LEAP trial who were
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separated in to peanut avoidance and peanut consumption groups for 12 months after
the LEAP trial. At the end of this period, participants who consumed peanuts for the
first 60 months of life then avoided for the 12 months had a 74% lower prevalence of
peanut allergies than those participants who continued to avoid peanuts for the 72
months that both trials collected data (Du Toit et al., 2016).
Both the LEAP trial and LEAP-On study show that early peanut introduction
into the infant diet can have lasting impact and reduction in allergy development. The
timing of food introduction is critical for allergy prevention. A systematic review by
Ierodiakonou et al. (2016) examined articles pertaining to various types of allergenic
food and risk for sensitization. Analysis specific to peanut introduction at 4-11 months
of age found a reduced frequency of 18 cases of peanut allergies per 1000 individuals
(with an incidence of 2.5%).
The research outcomes described above have created a paradigm shift in
practice. This transition has moved from delaying peanut introduction in infants to
promoting early consumption of peanuts; especially in those at-risk infants. In 2017, the
NIAID created a new guideline for providers to follow when infants are starting solid
foods. The three-part guidelines are based on patient allergy risk. Infants with severe
eczema and/or egg allergy are the highest risk for developing peanut allergies and these
infants should be seen by a specialist for allergy testing prior to consumption. Infants
with mild to moderate eczema and/or egg allergy should start consistent consumption
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of peanuts at or around six months of age. Finally, infants with no history of eczema
and/or egg allergy are considered low risk and may start consuming peanuts with
family preferences (Togias et al., 2017) (Table 1).
Providers play a key role in both assessing risk as well as counseling families on
early introduction of peanut containing foods. Experts found that without the provider
knowledge and implementation of updated guidelines, introduction of allergenic foods,
such as peanuts is delayed due to false beliefs that these foods should not be consumed
in infants with eczema (Fleischer et al., 2016). A national consensus statement
recommended that improved education and training of key stakeholders, such as
primary care providers, is needed in order for allergy prevention to be employed.
Education topics should include: risk factors and determinants of allergies, prevention
strategies, and improving diagnosis (Sicherer et al., 2017).
One small survey found that pediatric providers and allergists are more likely to
follow by the new NIAID guideline recommendations on early peanut consumption
compared to family practice providers (Abrams, Singer, Soller, & Chan, 2018). There
continues to be a lack of global knowledge and education of these recommendations,
along with routine implementation into practice.
This gap in practice was the foundation of this project, the purpose of which was
to implement a practice change to adequately assess risk factors for food allergies in
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infants being seen for their six-month well-child examination at a small, three provider
pediatric primary care office in Southern California.
Evidence-Based Practice Model
The Stevens Star Model of Knowledge Transformation was the framework for
this project. Components of the Stevens Star Model consider that research and
knowledge occur in stages over time to build impact. This model can be utilized for
evidence-based practice when there are many different types of knowledge such as:
randomized control trials, systematic reviews, guidelines, and consensus statements
(Melnyk & Fineout-Overholt, 2015). Understanding that evidence at all levels can have
an effect on implementing new practice is the foundation of both the Stevens Star
Model and this project. The Steven’s Star Model provided simple, easy to follow
guidance throughout the process of implementing peanut allergy risk assessment to
improve patient care (Stevens, 2013).
Methods
Study Design
This project took place over an eight-month period at a small, urban practice
with one lead physician, two nurse practitioners, three Medical Assistants (MA), and an
office manager. The clinic accepts all insurance types, with a predominance of patients
having public insurance. It is important to note that at this clinic there are no
computers in the patient rooms; providers use electronic charting after the visit. At
each well-exam, the medical assistant (MA) presents the provider with a form
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consisting of age-specific milestones and health surveillance prompts for the provider to
utilize during the exam.
Infants included in the project were those presenting for a six-month wellness
examination. Six-month age was chosen because the American Academy of Pediatrics
(AAP) recommends starting solid foods at or around six-months (American Academy
of Pediatrics, 2019). Infants were assessed for peanut allergy risk at the six-month
wellness-examination utilizing the NIAID 2017 guideline (Togias et al., 2017). Risk
factors included: a history of eczema and/or egg allergy that were categorized by
severity. Family history, seen as a moderate risk factor for food allergy, was also
assessed.
Stakeholder meetings were set up at this clinical site to present the NIAID
guideline and provide education on its importance for clinical practice. Providers were
very receptive to the implementation of this practice change. At these meetings
providers were educated on the project process and given education materials for
families of infants who would benefit from safe, early peanut consumption.
The allergy risk assessment was implemented by creating a provider alert on the
six-month wellness form to ask if the patient had any history of eczema, egg allergy, or
a family history of food allergies. If risk was identified, the provider educated and
counseled parents on stating starting peanut containing foods or the need for allergy
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testing. After the visit was completed, providers documented the assessment within the
“allergy” section on the electronic health record (EHR) note.
Eczema and Egg Allergy Severity
Patient history of eczema was measured both through chart review and
history/review of systems obtained during that visit. History of egg allergy was also
questioned and if the patient was positive the type of reaction would be documented.
Family History
Family history is not part of the NIAID guideline recommendations. There has
been discussion that there is a genetic component to food allergy development. This
measure was utilized to assess any association between children at-risk for developing
food allergy and family history.
Plans and Recommendations
Patients were stratified into high, moderate, and low/no risk categories based
upon provider assessment. Allergy testing would be advised to those infants within the
high-risk group. Recommendations to start consistent consumption of peanut
containing foods were given to patients in the mild/moderate category post-assessment.
Those with low/no risk were advised that the infant could start peanut consumption if
desired by the family. This was documented within the education and anticipatory
guidance section of the note for that patient visit.
Analysis
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Prior to implementation of this project, there was no standard or routine peanut
allergy risk assessment as part of the six-month well-exam. Data analysis was
performed by chart review of provider documentation of risk factors for peanut
allergies (eczema and/or egg allergy) and family history of food allergies within the visit
note.
Ethical Considerations
This evidence-based practice project was approved by both the pediatric practice
that participated and the University of San Diego Institutional Review Board. There
were no conflicts of interest in the implementation of this project.
Results
This project consisted of a four-month retrospective chart review of the four
months immediately prior to the implementation of the practice change. This was
followed by a four-month period of data collection after the practice change was
implemented. There were a total of 49 six-month well-exams in the pre-implementation
phase and 40 six-month well-exams in the post-implementation period. Average age in
the pre-implementation was 6-month 13 days and post-implementation 6 months 15
days. There was a 14.3% prevalence of eczema pre- and 22.5% prevalence postimplementation. No children were identified having an egg allergy. Due to a large
amount of missing data, patient ethnicity was not included in the data analysis. In
October 2017, this clinic had a change in the EHR and many patient charts were not
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updated to include this key data variable. No children were identified as having an egg
allergy.
There was an improvement in the practice change by adding routine allergy
assessment to the six-month well-exam. There was overall provider uptake of allergy
documentation of 72.5% at the end of data collection. July, the first month after the
practice change was implemented, had the lowest documentation rate, 40%, this month
also had the highest number of visits at 15. After this first month, the allergy
assessment was highlighted on the six-month paper provider form and the field for
documentation was added to the EHR. After these changes were made, the
documentation rate increased from 40% to 92.9% from July to August. September had a
100% documentation rate and October, the final month had a 90% rate (Figure 1).
Seven of the infants who presented for their visit in the pre-implementation
phase were at risk for developing peanut allergy, none of whom were identified. In the
post-implementation phase, nine infants had a history of eczema. All of these were in
the mild/moderate category. Three of these infants that would have benefited from
education of early peanut consumption were missed. These children all presented to
clinic in July (the first month after the practice change was implemented). There was an
overall improvement of identifying infants with peanut allergy risk factors by 66%
(Figure 2).
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There were a total of 29 documented allergy risk assessments; of those completed
6 infants had history of family food allergy. Food allergies included: pineapple, wheat,
and Shellfish/Shrimp. None of the infants who presented to clinical with a family
history of food allergies had a history of eczema or egg allergy (Figure 3).
Discussion
This project successfully created a practice change, implementing routine allergy
risk-assessment at the six-month well-exam at a small pediatric office. Early
introduction of allergenic foods can reduce allergy prevalence and there remains a large
gap in knowledge of primary care providers (Abrams et al., 2018). Providers in primary
care play a pivotal role in addressing new practice change and early consumption of
peanuts in high-risk infants. Through utilization of provider alert and documentation
field, there was an improvement in assessing infants for peanut allergy risk.
Providers at this practice are given thirty-minute time intervals for all wellexams. Adding an allergy risk assessment took no more than 3 minutes of provider
time to assess risk and educate parents. This could be done within the time it takes to
do a physical exam and added no cost to the clinic or patients.
The benefits to this project have the potential to generate healthcare and patient
long-term savings. These savings would be result of decreased Emergency Room (ER)
visits and reduced medication need because of a reduction in peanut allergy prevalence.
A report by Blue Cross Blue Shield (2018) estimated that the cost of one ER visit for an
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anaphylactic episode in 2016 was $1,419, with a $373 out-of-pocket cost. The cost for an
epinephrine auto-injector, the medication administered during an allergic reaction, is
$493 for name brand and $234 for generic. Peanut allergies are a life-long diagnosis and
purchasing of medication is continuous. Additionally, one patient with a peanut
allergy may encounter multiple ER visits throughout his or her lifetime. Cost savings
are therefore far greater than demonstrated in this paper. Implementing allergy
prevention practices in primary care can significantly reduce lifelong patient health care
costs.
Limitations to this project include the small size of the practice, making it
difficult to generalize the intervention to larger systems. Future evidence-based
practice projects focusing on allergy risk-assessment utilizing a provider alert should be
done with a larger sample size.
In regard to family history, infants with peanut allergy risk factors did not have a
family history of food allergies. This was again a small sample size and showed no
association between risk factors for peanut allergy and family history of food allergy.
Additional projects similar to this with a larger population may show the association of
family history of food allergy to risk factors such as eczema.
An important barrier to implementation of this project was that this clinic does
not use computers within patient rooms, which is why paper documentation was used.
Results did show that use of this reminder and updates to the EHR increased the
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performance of assessment. Compliance outcomes may have been improved with
electronic prompts by in-room charting. Other contextual factors involved were
creating provider motivation via updates on compliance and applying a field for
documentation to create a convenient way for providers to chart the risk-assessment.
Data collection took over a four-month period, although there was great improvement
in adherence to change in practice, a longer time period or follow-up would be
beneficial to assess sustainability.
There was only one visit during the month of September. One of the providers
who predominately sees the newborn patients was out on leave six months prior. This
absence along with temporal/seasonal changes could have influenced a decrease in
visits.
Diagnosing a patient with mild/moderate versus severe eczema is a subjective
and provider specific; thus, affecting the recommendation to start early consumption of
peanuts or referral for allergy testing prior to initiating consumption. Some infants may
have a later onset of eczema, after age six months. Providers will need to assess risk
and address peanut consumption at later ages when a child develops eczema.
The NIAID 2017 addendum guideline primarily focuses on implementing peanut
containing foods into the at-risk infant; those with eczema and/or egg allergy history
(Togias et al, 2017). A new research study that assessed food anaphylaxis in children
and infants showed that of infants presenting to the ER with food allergy, only 21% had
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a history of eczema/atopic dermatitis (Samady, Trainor, Smith, & Gupta, 2018).
Outcomes of this trial show that even infants with no risk factors for food allergy could
still benefit from early peanut consumption. Additional research and evidence-based
projects, such as this study, are needed to understand the long-term benefits of this
novel guideline.
Conclusion
Implementing change into practice is a process that evolves over time. This
evidence-based practice project provides baseline implementation of the NIAID
guidelines to primary prevention of peanut allergies into clinical use. This project
provides a framework for future data collection and evidence-based projects on
allergies that have not been previously studied. Subsequent projects will be able to
build off of baseline guidelines and focus on other topics including: precise diagnosis of
an allergy in primary care, parent perception of early peanut consumption, and reasons
for provider and patient non-compliance. The interventions and outcomes of this
project lay a sustainable foundation to creating provider practice change and
prevention of lifelong peanut allergies to improve patient outcomes.
Funding
This study was not supported by any funding.
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Table 1.
Summary of NIAID Guideline Addendum
Addendum
Measures
Guideline 1
Severe Eczema and/or Egg
Allergy

Guideline 2

Mild/Moderate Eczema
and/or Egg Allergy

Guideline 3

No Eczema or Egg Allergy

Recommendation
Consider allergy (IgE or
skin prick) testing prior to
consumption of peanut
containing foods
Start consistent
consumption of peanut
containing foods as early
as 6 months
May start peanut
containing foods as early
as 6 months and with
cultural preferences

Note. The 2017 NIAID Addendum Guideline to Prevention of Peanut Allergy in the
United States was used to create this table (Togias et al., 2017)
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Table 2.
Population Demographics
Pre-Implementation
(March 1, 2018 – June 30, 2018)
Total Visits
49

Post-Implementation
(July 1, 2018 – October 31, 2018)
Total Visits
40

Male

28 (57.1%)

Male

24 (60%)

Female

21 (42.9%)

Female

16 (40%)

Insurance Coverage
Public

28 (57.1%)

Insurance Coverage
Public
29 (72.5%)

Private

21 (42.9%)

Private

11 (27.5%)

Mean Age at Visit
Eczema

6 m 13 d
(5m17d – 8m14d)
7 (14.3%)

Mean Age at
Visit
Eczema

6 m 15 d
(6m1d – 7m29d)
9 (22.5%)

Egg Allergy

0 (0%)

Egg Allergy

0 (0%)

Identified at risk by
Provider

0 (0%)

Identified at risk
by Provider

6 (66.7%)

Note. Ethnicity was not included in this project due to missing data
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Figure 1.
Provider Documentation Rate of Allergy Assessment
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16

100%

PRACTICE CHANGE

14
12

P
R
A
C
T
I
E

10
8
6
4
2
0

0%
March

April

May

June

Total 6 Month Visits

July

August

September October

% Assessed

28
Figure 2.
Post-Implementation Missed Assessments of Infants at Risk for Peanut Allergy

Missed Assessments of
Infants with Allergy Risk
33%

67%

Missed
(n=3)
Assessed
(n=6)

29
Figure 3.
Family History of Food Allergy

Family History of Food
Allergy
Pinapple (n=2)
Wheat (n=1)

Shellfish/Shrimp (n=3)

Note. Infants with family hx of food allergies did not present to visit with hx of eczema or egg
allergy
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Concluding Essay: Reflections on Growth in Advanced Practice Nursing Role
Reflecting back on the last four years it is still hard to believe that my time as a
doctoral student has come to an end. I have grown incredibly from the start of this
program and have gained a new perspective on what it means to be a Doctor of
Nursing Practice (DNP). Transitioning to primary care has allowed me to understand
the vital importance of health promotion, maintenance, and preventative care. Growing
into a DNP over the last four years has given me to confidence to be able to be an
independent advanced practice provider. I have developed the knowledge and
responsibility to care for patients, instill motivation, and create strong patient/provider
relationships that are vital to all patients, especially those with complex medical
conditions.
Implementing an evidence based-guideline into clinical practice has taught me
the need for providers to bring research into patient care. I learned that as a DNP it is
my responsibility to bring new practices and policies into my direct care in order to
improve patient outcomes, as well as to evaluate a new change as it evolves. The
foundations I have from the process of implementing my own project will help me with
others as I begin practicing as a DNP.
It is bittersweet to officially be done with my time as a doctoral student. I have
learned an incredible amount from faculty, preceptors, and my peers who have all
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mentored me along the way. I feel prepared to utilize the foundation I have established
and I am excited to bridge into my new professional DNP role.
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Appendix C
Abstract for CANP 42nd Annual Conference
Peanut allergies are the leading cause of death from food anaphylaxis. In 2017, the
National Association of Allergy and Infectious Disease (NIAID) issued a guideline for use by
primary care providers to identify infants who would benefit from early peanut consumption.
Many providers have not yet implemented these guidelines in clinical practice. The purpose of
this project is to implement a practice change to improve assessment of risk factors for food
allergies utilizing the NIAID guideline in infants at their six-month well-child examination at a
pediatric primary care practice. Risk factors assessed included: a history of eczema and/or egg
allergy categorized by severity. Family history, seen as a moderate risk factor for food allergy,
was also assessed. The risk assessment was implemented by creating a provider alert on sixmonth wellness forms and a field for documentation into the electronic health record. Providers
were given education materials for families of infants who would benefit from safe, early peanut
consumption. This project is important for clinical practice. Infants begin consuming solid
foods at or around six-months of age and this is a critical time to address risk for future allergies
and educate families on benefits of early consumption of allergenic foods, such as peanuts.
Providers in primary care play a pivotal role in addressing new practice change. This project
provides a framework for provider identifications of at-risk infants to move toward prevention of
lifelong peanut allergy.
Poster Presentation Approval Letter
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Appendix D
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Appendix E
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Background and Significance
• It is estimated that 4-6% of children suffer from food allergies and 30.4%
of those children are allergies to more than one type of food
• Food allergies have increased over the last two decades and are a
growing public health concern
• Peanut allergies have increased significantly from 0.4% in 1999 to 2% in
2010 and are the leading cause of death from food anaphylaxis in the
United States
• Early introduction of peanut protein containing foods can prevent longterm allergy in at-risk infants
• In 2017 the National Institute of Allergy and Infectious Disease (NIAID)
changed guidelines to prevent peanut allergies
• Knowledge gaps remain among primary care providers and there is a
global lack of implementation of routine allergy assessment into clinical
practice
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Family History and Food Allergies

Family history is not part of the NIAID guideline
addendum; however it is a moderate risk factor for food
allergy development. Although food allergies are
thought to be epigenetic, the influence of genetics on
food allergy remain unclear.

Needs Assessment
• Providers at clinical site were not utilizing the NIAID
guidelines in clinical practice and patients were not being
assessed for peanut allergy risk

• Current patient intake does not specifically ask about
family food allergy history; a moderate risk factor for food
allergies
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Purpose/Aims
• The purpose of this project was to implement a practice
change to adequately assess risk factors for food
allergies in infants being seen for their six-month wellchild examination at a small, three provider pediatric
primary care practice in Southern California
• This project was developed through utilizing the 2017
NIAID Guideline recommendations on early peanut
consumption in at-risk infants

Framework/EBP Model

The Stevens Star Model of Knowledge Transformation

42

Synopsis of the Evidence
•

The Learning Early About Peanut Allergy (LEAP) trial showed
that children with peanut allergy risk factors had both a 86.1%
and 70% risk reduction in prevalence of peanut allergies in early
consumption groups compared to peanut avoidance groups at
60 months (Du Toit et al., 2015)

•

The LEAP-On trial resulted in continued 74% reduced
prevalence of peanut allergy in children with early consumption
of peanuts after 12 month avoidance period (Du Toit et al., 2016)

•

Early Introduction of allergenic foods, such as peanuts, can
reduce allergy prevalence by up to 18 per 1,000 cases

•

Starting allergenic foods in children with eczema may be
delayed due to false beliefs that these foods should not be
consumed

Project Plan Process
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Timeline
January 2018-June 2018
• Pre-implementation phase
• Meetings with providers to discuss need for practice change and obtain approval

July 2018
• IRB Approval
• Retrospective chart review of records March 2018-June 2018

July 2018-October 2018
• Implementation phase

November 2018-December 2018
• Data Analysis

Spring 2019
• Data Dissemination
•
•
•
•

Stakeholder Presentation
Research Day
Poster Presentation at CANP 2019 Conference
Completion of Final Manuscript

Results: Patient Demographics
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Results: Provider Compliance

Results: Risk Stratification and Missed
Assessments (Post-Implementation)
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Results: Family History
Family History of Food Allergy

Pinapple (n=2)
Wheat (n=1)
Shellfish/Shrimp (n=3)

Note. Infants w ith family hx of food allergies did not
present to visit w ith hx of eczema or egg allergy

Cost-Benefit Analysis
• Implementing an allergy risk assessment and giving education
adds 3 minutes of provider time done in a routine well child
visit.
• Counseling parents on early consumption of peanuts can
greatly reduce development of peanut allergies and decrease
Emergency Room (ER) visits
• The estimated cost for one ER visit from an anaphylactic
episode in 2016 was $1,419 with an out-of-pocket cost of $373;
the cost for an Epinephrine auto-injector is $234-$493.
• Improved allergy prevention practices in primary care can
significantly reduce patient health care costs. Costs above are
for only one episode of anaphylaxis and one auto-injector
purchase
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Conclusions
• Infants begin consuming solid foods at or around six-months of
age that is also a time of a routine well-exam
• This is an critical opportunity to address risk for peanut allergy
development and educate families on benefits of early
consumption of allergenic foods
• Providers in primary care play a pivotal role in addressing new
system changes; especially when there is a paradigm shift in
practice
• This prevention project implemented an evidence-based,
routine allergy risk assessment of the 6-month infant into
clinical practice

Implications for Clinical Practice
• This evidence-based practice project demonstrates the
importance for primary care providers to routinely
assess for food allergy risk in the six-month infant
• Families can be informed on the importance of early
peanut introduction at a time where prevention of
peanut allergy is possible
• Providers may need to consider allergy prevention
education with all infants as new research indicated a
small percent of children presenting to the ER with
food allergy had a history of risk factors
…stay tuned for more updates!
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Appendix F

AACN DNP Essentials/NONPF Competencies/USD DNP Program Outcomes
Exemplars
AACN DNP Essentials & NONPF
Competencies

USD DNP Program
Objectives

Exemplars
Provide bulleted exemplars that
demonstrates achievement of each
objective
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DNP Essential I: Scientific
Underpinnings for Practice
NONPF: Scientific Foundation
Competencies

2. Synthesize nursing and
other scientific and ethical
theories and concepts to
create a foundation for
advanced nursing practice.

The scientific foundation of nursing
practice has expanded and includes a
focus on both the natural and social
sciences including human biology,
genomics, science of therapeutics,
psychosocial sciences, as well as the
science of complex organizational
structures. In addition, philosophical,
ethical, and historical issues inherent in
the development of science create a
context for the application of the natural
and social sciences.

DNP Essential II: Organizational &
System Leadership for Quality
Improvement & Systems Thinking
NONPF: Leadership
Competencies/Health Delivery System
Competencies
Advanced nursing practice includes an
organizational and systems leadership
component that emphasizes practice,
ongoing improvement of health
outcomes, and ensuring patient safety.
Nurses should be prepared with
sophisticated expertise in assessing
organizations, identifying system’s
issues, and facilitating organizationwide changes in practice delivery. This
also requires political skills, systems
thinking, and the business and financial

5. Design, implement, and
evaluate ethical health care
delivery systems and
information systems that
meet societal needs and
ensure accountability for
quality outcomes.

Fall 2015
 Developed a solid foundation
of human biology and various
disease states and the
pathophysiological changes
within the body (APNC 520).
Spring 2016
 Obtained a strong knowledgebase of the pharmacodynamics
and pharmacokinetics of drugs
as well as an understand of how
to treat various primary care
conditions through
pharmacological therapy
(APNC 523).
Fall 2016
 Established an understanding of
genomics and the pathogenesis
for various genetic diseases, the
ethical issues involved, and
how to assess and educate
patients and families on their
own genetic/environmental
risks (DNPC 622).
Spring 2018
 Utilized the ACE Star Model to
guide development of an EBP
project to implement a practice
change and improve food
allergy risk assessment in
infants (DNPC 686)
Summer 2017
 Presented a case study
presentation on the Quality in
Pediatric Subspecialty Care
(QPSC) initiative and goals to
improve care and standardizing
outcomes of various, rare
pediatric conditions (DNPC
626).
 Constructed a monthly budget
and analysis for a primary care
clinic and implications
regarding a variance report
(DNPC 653).
 Developed an understanding of
the “worth of a Nurse
Practitioner” and how to
calculate salary with including
overhead and marginal costs
(DNPC 653).
 Created a “financial case” to
discuss the money needed and
revenue projected for
implementing standing orders
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acumen needed for the analysis of
practice quality and costs.

DNP Essential III: Clinical
Scholarship & Analytical Methods for
Evidence-Based Practice
NONPF: Quality
Competencies/Practice Inquiry
Competencies
Scholarship and research are the
hallmarks of doctoral education.
Although basic research is viewed as the
first and most essential form of scholarly
activity, an enlarged perspective of
scholarship has emerged through
alternative paradigms that involve more
than discovery of new knowledge. These
paradigms recognize: (1) the
scholarship of discovery and integration
“reflects the investigative and
synthesizing traditions of academic
life”; (2) scholars give meaning to
isolated facts and make connections
across disciplines through the
scholarship of integration; and (3) the
scholar applies knowledge to solve a
problem via the scholarship of
application that involves the translation
of research into practice and
dissemination and integration of new
knowledge.

4. Incorporate research
into practice through
critical appraisal of
existing evidence,
evaluating practice
outcomes, and developing
evidence-based practice
guidelines.

to improve HPV vaccination
rates (DNPC 626).
 Constructed a three-year
financial prospectus on clinic
revenue form improving
vaccination rates. Also, gained
understanding in how to make a
prospectus for other EBP
projects. (DNPC 626)
Spring 2018
 Wrote a paper regarding
implementing a program to
assess peanut allergy risk at 6month-old well visits to prevent
long-term allergy development
(DNPC 686).
Fall 2015
 Synthesized and critiqued
evidence-based practice articles
of various pathophysiological
states through Clinical Grad
Round assignments and related
to current or future practice.
(APNC 520).
 Reviewed current literature to
develop a PICO question and
summarized findings to write a
paper titled “Retinopathy of
Prematurity and Oxygen
Saturations in the Premature
Infant”

(DNPC 611).
Spring 2016
 Synthesized Complementary
and Alternative Medicine
evidence to create a patient
pamphlet on the safe use of
milk thistle (APNC 523).
Fall 2016
 Presented a case-study
presentation and the genetic
components of Prader Willi
Syndrome and the most up-todate treatment (DNPC 622).
 Presented and wrote a
manuscript regarding
Hemophilia, its pathogenesis,
treatment, implications for
patients, and future (DNPC
622).
 Created a screening program
and recommendations for skin
cancer at primary care
appointments and how to assess
risk (DNPC 625).
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DNP Essential IV: Information
Systems/Technology & Patient Care
Technology for Improvement &
Transformation of Health Care
NONPF: Technology & Information
Literacy Competencies
DNP graduates are distinguished by
their abilities to use information
systems/technology to support and
improve patient care and health care
systems, and provide leadership within
healthcare systems and/or academic
settings. Knowledge and skills related
to information systems/technology and
patient care technology prepare the
DNP graduates apply new knowledge,
manage individual and aggregate level
information, and assess the efficacy of
patient care technology appropriate to a
specialized area of practice along with
the design, selection, and use of
information systems/technology to
evaluate programs of care, outcomes of
care, and care systems. Information
systems/technology provide a
mechanism to apply budget and
productivity tools, practice information
systems and decision supports, and webbased learning or intervention tools to
support and improve patient care.

7. Incorporate ethical,
regulatory, and legal
guidelines in the delivery
of health care and the
selection, use, and
evaluation of information
systems and patient care
technology.

Sumer 2017
 Made a quality improvement
presentation regarding
implementing standing orders
to improve HPV vaccination
rates (DNPC 653).
Summer 2018
 Obtained IRB approval for a
scholarly project to assess
peanut allergy risk in the 6month-old infant population
through utilizing the NIAID
guidelines (DNPC 630).
Fall 2016
 Received Biomedical Research
and Human Certification
through CITI (DNPC 625).
Spring 2017
 Developed an understanding of
health care technology and
implementing new informatics
through work-flows and
systems development, while
eliminating lean waste within
the work environment. (HCIN
540).
 Created a report on current
sleep deficits within the United
States adult population and
utilized learned Excel
knowledge to best display data
(HCIN 540).
Summer 2017
 Gained knowledge on the use
of standing orders in the EHR
and how this can streamline
workflow in patient care
(DNPC 626).

51
DNP Essential V: Health Care Policy
for Advocacy in Health Care
NONPF: Policy Competencies
Health care policy, whether created
though governmental actions,
institutional decision-making, or
organizational standards, creates a
framework that can facilitate or impede
the delivery of health care services or
the ability of the provider to engage in
practice to address health care needs.
Engagement in the process of policy
development is central to creating a
health care system that meets the needs
of its constituents. Political activism
and a commitment to policy development
are central elements of DNP practice.

3. Demonstrate leadership
in collaborative efforts to
develop and implement
policies to improve health
care delivery and outcomes
at all levels of professional
practice (institutional,
local, state, regional,
national, and/or
international).

Spring 2016
 Presented and developed a
manuscript on current health
care disparities that remain
within the United States and
policies relating to Healthy
People 2020 (DNPC 648).
 Created a policy brief on
increasing access to health care
for children through SchoolBased Health Centers (DNPC
648).

Spring 2017
1. Demonstrate advanced
 Gained the ability, through
levels of clinical practice
utilizing reflective practice and
within defined ethical,
theory, to be a leader when
legal, and regulatory
practicing and to provide
parameters in designing,
NONPF: Leadership Competencies
therapeutic care to patients
(DNPC 610).
implementing, and
Summer
2017
Today’s complex, multi-tiered health
evaluating evidenced
Presentation
on the QPSC
care environment depends on the
based, culturally competent
process approach toward
contributions of highly skilled and
therapeutic interventions
improving pediatric population
knowledgeable individuals from multiple for individuals or
health outcomes through
national databases,
professions. In order to accomplish the aggregates.
improvement collaborates, and
IOM mandate for safe, timely, effective,
web-based modules (DNPC
3.
Demonstrate
leadership
efficient, equitable, and patient-centered
626).
in collaborative efforts to
care in this environment, health care
Summer 2017-Spring 209
develop and implement
professionals must function as highly
 Student Representative for the
policies to improve health
collaborative teams. DNPs have
San Diego NAPNAP Chapter.
care
delivery
and
outcomes
Fall
2017
advanced preparation in the
 Gave a podium presentation
at all levels of professional
interprofessional dimension of health
“NICU and Beyond:
practice (institutional,
care that enable them to facilitate
Adventures in Developmental
local, state, regional,
collaborative team functioning and
Assessment” at the San Diego
national, and/or
overcome impediments to
NAPNAP Chapter fall 2017
international).
event on the premature infant.
interprofessional practice. DNP
Fall 2018
graduates have preparation in methods
 Submitted an abstract in
of effective team leadership and are

DNP Essential VI: Interprofessional
Collaboration for Improving Patient
& Population Health Outcomes

fulfilment of DNP project that

52
prepared to play a central role in
establishing interprofessional teams,
participating in the work of the team,
and assuming leadership of the team
when appropriate.

DNP Essential VII: Clinical
Prevention & Population Health for
Improving Nation’s Health
NONPF: Leadership Competencies
Consistent with national calls for action
and with the longstanding focus on
health promotion and disease prevention
in nursing, the DNP graduate has a
foundation in clinical prevention and
population health. This foundation
enables DNP graduates to analyze
epidemiological, biostatistical,
occupational, and environmental data in
the development, implementation, and
evaluation of clinical prevention and
population.

6. Employ a population
health focus in the design,
implementation, and
evaluation of health care
delivery systems that
address primary,
secondary, and tertiary
levels of prevention.

was accepted to present at the
CANP 2019 conference (DNPC
630).
Spring 2019
 Data dissemination of DNP
Project “Spreading the News
about Peanuts: Implementing
an Infant Allergy Risk
Assessment”
1. DNP Presentation Day
2. Poster Presentation at CANP 42nd
2019 Conference
3. Stakeholder Presentation
4. Completion of Final Manuscript
Fall 2016
 Created secondary screening
recommendations for skin
exams at primary care
appointments (DNPC 625).
Summer 2017
 Created a driver diagram on
improving HPV vaccination
rates in the pediatric male
population; discussed the
primary drivers and need for
cancer prevention (DNPC 626).
Fall 2017
 Developed an understand in
health promotion for the
pediatric, adult, and geriatric
population and
recommendations for
prevention (NPTC 602).
Summer 2018
 Stated an evidence-based
practice project on assessing
peanut allergy risk in the 6month-old infant population to
improve systems on early
consumption of peanuts and
prevention of lifelong allergy
(DNPC 630).

53
1. Demonstrate advanced
levels of clinical practice
within defined ethical,
NONPF: Independent Practice/Ethics legal, and regulatory
parameters in designing,
Competencies
implementing, and
The increased knowledge and
evaluating evidence-based,
sophistication of healthcare has resulted culturally competent
in the growth of specialization in
therapeutic interventions
nursing in order to ensure competence
for individuals or
in these highly complex areas of
aggregates.
practice. The reality of the growth of
specialization in nursing practice is that
no individual can master all advanced
roles and the requisite knowledge for
enacting these roles. DNP programs
provide preparation within distinct
specialties that require expertise,
advanced knowledge, and mastery in
one area of nursing practice. A DNP
graduate is prepared to practice in an
area of specialization within the larger
domain of nursing.
DNP Essential VIII: Advanced
Nursing Practice

Fall 2017
 Became proficient on health
promotion and prevention
through the lifespan. Utilized
this knowledge at an adult
community clinic in an
underserved population (NPTC
604).
Spring 2018
 Gained competence in the role
of a Student Health Nurse
Practitioner as well as
independence in assessing and
treating common acute illness
in both adult and pediatric
populations (NPTC 605).
Summer 2018
 Developed a foundation and
understanding of pediatric
gastrointestinal disorders and
became proficient in the duties
of the nurse practitioner in
specialty care (NPTC
605/NPTC 549).
Fall 2018
 Through the Family Health
Centers ICPP program,
received advanced knowledge
of managing mental health and
substance use disorders in
primary care and the use of
“soft handoffs” in clinical
practice (NPTC 608).
Spring 2019
 Became knowledgeable of
congenital heart defects and the
role of the PNP in pre-operative
and post-operative outpatient
appointments for children
having cardiac surgery (NPTC
609).

